Investigating omega-3 fatty acids’ neuroprotective effects in repetitive subconcussive neural injury: Study protocol for a randomized placebo-controlled trial
PLOS One · 2025
DOI: 10.1371/journal.pone.0321808 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Lauren H Beauregard und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kinesiology, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, United States of America. Hauptthemen laut MEDLINE: Brain Concussion, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Omega-3. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Soccer (football) is the most popular sport globally, with 265 million players across all ages and sexes. Repetitive subconcussive head impacts due to heading of the soccer ball can pose threats to healthy brain development and aging. Omega-3 fatty acids, especially docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), may have neuroprotective effects, but it remains unclear what aspects of neural health benefit from DHA+EPA when faced with subconcussive head impacts. In a randomized placebo-controlled trial, 208 soccer players will complete baseline measures including demographics, blood sampling, dietary recalls, and psychological assessment. Participants will be randomly assigned to ingest DHA+EPA [3.4g/d: DHA 2.4g+EPA 1.0g] or placebo daily for 8 weeks followed by a subconcussion intervention phase. During the subconcussion intervention, participants will perform a session of 20 controlled soccer headings, with a second session 24 hours later. Blood samples, neuroimaging data, autonomic reactivity, and clinical measures (symptoms, oculomotor, cognition) will be collected pre-heading and 24-hour post-1 st session, 24-hour post-2 nd session, and 7-day post-2 nd session. The primary hypothesis is that DHA+EPA pretreatment will promote neuronal and astrocyte resiliency to subconcussive head impacts, as assessed by blood biomarkers of brain injury, axonal microstructure measured by diffusion tensor imaging, and whole-brain resting-state connectivity. It is proposed that pretreatment will preserve autonomic function, as assessed by the cold pressor test (CPT), as well as oculomotor and cognitive function, even after head impacts. Data from this trial will help clarify the combined effect of DHA+EPA on brain molecular, cellular, and physiological health in response to subconcussive head impacts. If the hypotheses are confirmed, the findings will support a highly practical intervention for mitigating the neurodegenerative cascade triggered by head impacts. Trial registration: ClinicalTrials.gov NCT06736925
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Kinesiology, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, United States of America.
- Department of Emergency Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
- Program in Neuroscience, The College of Arts and Sciences, Indiana University, Bloomington, Indiana, United States of America.
- Department of Psychological and Brain Sciences, College of Arts and Sciences, Indiana University, Bloomington, Indiana, United States of America.
- Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
- School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
ORCID-Profile: Blair D Johnson, Zhongxue Chen, Sharlene D Newman, Keisuke Kawata
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Beauregard, L. H., Bazarian, J. J., Johnson, B. D., Cheng, H., Ellis, G., Kronenberger, W., Calder, P. C., Chen, Z., Silveyra, P., Quinn, P. D., Newman, S. D., Mickleborough, T. D., & Kawata, K. (2025). Investigating omega-3 fatty acids’ neuroprotective effects in repetitive subconcussive neural injury: Study protocol for a randomized placebo-controlled trial. PLOS One. https://doi.org/10.1371/journal.pone.0321808
Vancouver
Beauregard LH, Bazarian JJ, Johnson BD, Cheng H, Ellis G, Kronenberger W, et al. Investigating omega-3 fatty acids’ neuroprotective effects in repetitive subconcussive neural injury: Study protocol for a randomized placebo-controlled trial. PLOS One. 2025. doi:10.1371/journal.pone.0321808
BibTeX
@article{Beauregard2025,
author = {Beauregard, Lauren H and Bazarian, Jeffrey J and Johnson, Blair D and Cheng, Hu and Ellis, Gage and Kronenberger, William and Calder, Philip C and Chen, Zhongxue and Silveyra, Patricia and Quinn, Patrick D and Newman, Sharlene D and Mickleborough, Timothy D and Kawata, Keisuke},
title = {Investigating omega-3 fatty acids’ neuroprotective effects in repetitive subconcussive neural injury: Study protocol for a randomized placebo-controlled trial},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0321808}
}
EUVIMED